ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
63 546,28
0,21%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Astria Therapeutics Inc (ATXS)

  7. Astria Therapeutics Inc (ATXS) Actualités

ATXS Astria Therapeutics Inc

9,00
-0,17 (-1,85%)
27 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Astria Therapeutics Inc ATXS NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,17 -1,85% 9,00 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
9,18 8,97 9,46 9,00 9,17
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
09/4/202414:00BWAstria Therapeutics Appoints Sunil Agarwal to Its Board of..
03/4/202422:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
25/3/202412:30BWAstria Therapeutics Announces Positive Initial..
05/3/202422:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
04/3/202423:22EDGAR2Form 8-K - Current report
04/3/202423:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/3/202422:10BWAstria Therapeutics Reports Fourth Quarter and Full Year..
04/3/202422:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/2/202414:00BWAstria Therapeutics to Present at Upcoming American Academy..
14/2/202421:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202421:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202414:36EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202414:00BWAstria Therapeutics to Present at Upcoming Oppenheimer 34th..
05/2/202422:00BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
31/1/202415:00EDGAR2Form 8-K - Current report
31/1/202414:59EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
30/1/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202415:08BWAstria Therapeutics Announces Pricing of $125 Million..
30/1/202412:01EDGAR2Form 8-K - Current report
29/1/202422:39EDGAR2Form 144 - Report of proposed sale of securities
16/1/202422:18EDGAR2Form SC 13G - Statement of acquisition of beneficial..
05/1/202414:30EDGAR2Form 8-K - Current report
02/1/202422:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
28/12/202320:09EDGAR2Form S-3/A - Registration statement under Securities Act of..
20/12/202322:30EDGAR2Form 8-K - Current report
15/12/202314:30EDGAR2Form S-3 - Registration statement under Securities Act of..
04/12/202322:00BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
27/11/202314:00BWAstria Therapeutics to Present STAR-0215 Data at the 2023..
21/11/202314:00BWAstria Therapeutics to Present at Upcoming 6th Annual..
13/11/202322:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202314:06EDGAR2Form 8-K - Current report
13/11/202314:00BWAstria Therapeutics Reports Third Quarter Financial Results..
10/11/202314:00BWAstria Therapeutics Presents New Phase 1a Data Confirming..
09/11/202314:00BWAstria Therapeutics to Present at Upcoming Jefferies London..
03/11/202313:10BWAstria Therapeutics to Present New STAR-0215 Data at the..
02/11/202321:00BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
30/10/202313:00BWAstria Therapeutics to Report Third Quarter 2023 Financial..
12/10/202323:04EDGAR2Form 8-K - Current report
12/10/202323:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/10/202314:00EDGAR2Form 8-K - Current report
12/10/202301:14BWAstria Therapeutics Announces Pricing of $64 Million..
11/10/202323:14EDGAR2Form 8-K - Current report
11/10/202323:10BWAstria Therapeutics Announces Exclusive Worldwide License..

Dernières Valeurs Consultées

NASDAQ
ATXS
Astria Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés